DSCSA 582g1_Exemptions_for_Connected_tps_Oct_2024_final_signed.pdf
Waivers and Exemptions Beyond the Stabilization Period FDA.pdf
9.27.24 FDA Response to Rep Good.pdf
VA Congressional Letter to FDA Re EMS Drug Box Letter 09 12 2024.pdf
VML Letter on Impact of Medication Exchange Transition 08 28 2024.pdf
USDAMedicationsLetter82624.pdf
DEA Guidance 7_3_24.pdf
DEA notice of proposed rules for EMS drug kits.pdf
FDA Guidance Document Draft - Identifying Trading Partners Under the Drug Supply Chain Security Act.pdf
Requirements-for-Transactions-with-First-Responders-under-Section-582-of-the-Federal-Food--Drug--and-Cosmetic-Act—-Compliance-Policy-Guidance-for-Industry.pdf
Drug-Kit-Regulations-Reminder-April-19-2024.pdf
Memorandum - Changes to Virginia EMS Drug Box Exchange Program.pdf
2-24 Report - VA Regional EMS Medication Kit Transition Workgroup Final.pdf
EMS-replenishment_DEA-DSCSA-and-Anti-kickback-requirements-November-2023.pdf
